Skip to main content
Clinical Trials/CTRI/2024/07/071205
CTRI/2024/07/071205
Not yet recruiting
Phase 3

A Controlled Clinical Study To Evaluate The add on effect of Panchakola Sidda Yavagu over Simhanada Guggulu on Inflammatory Biomarkers in Amavata vis-a-vis Rheumatoid Arthritis - nil

DrShantamma0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Sponsor
DrShantamma
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
DrShantamma

Eligibility Criteria

Inclusion Criteria

  • Subjects comes under diagnosed criteria of Amavata with special reference to Rheumatoid Arthrtis subjects age between 30\-60 years,irrespective gender,sex will be selected and Panchakola sidda yavagu and simhanada will be provided to one group and for another group only simhanada guggulu will be given for 14 days to assess the inflammatory changes in blood

Exclusion Criteria

  • 1\.Subjects with chronic Systemic disorders like CHD,CKD,CA and who are on prolonged Medication(Steroids)
  • 2\.Chronic patients of RA (more than 10 years)
  • 3\.Pregnant and Lactating women will be excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials